(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|
Turnover | 7.07%13.51B | 11.31%12.62B | --11.34B |
Operating income | 7.07%13.51B | 11.31%12.62B | 11.34B |
Cost of sales | -1.57%-7.48B | -15.63%-7.36B | ---6.37B |
Operating expenses | -1.57%-7.48B | -15.63%-7.36B | -6.37B |
Gross profit | 14.76%6.04B | 5.79%5.26B | 4.97B |
Selling expenses | -5.39%-4.09B | -3.22%-3.88B | ---3.76B |
Administrative expenses | -13.41%-300.56M | -4.66%-265.03M | ---253.24M |
Research and development expenses | -25.07%-61.51M | -0.41%-49.18M | ---48.98M |
Impairment and provision | 85.98%-3.82M | -387.15%-27.22M | --9.48M |
-Other impairment is provision | 85.98%-3.82M | -387.15%-27.22M | --9.48M |
Special items of operating profit | 0.34%338.13M | 18.08%336.99M | --285.38M |
Operating profit | 39.50%1.92B | 14.06%1.38B | 1.21B |
Financing cost | -2,529.31%-42.52M | 9.26%-1.62M | ---1.78M |
Earning before tax | 36.57%1.88B | 14.10%1.38B | 1.21B |
Tax | -41.47%-547.06M | -11.33%-386.7M | ---347.36M |
After-tax profit from continuing operations | 34.66%1.33B | 15.22%988.72M | 858.14M |
Earning after tax | 34.66%1.33B | 15.22%988.72M | 858.14M |
Minority profit | 286.66%2.03M | ---1.09M | ---- |
Profit attributable to shareholders | 34.30%1.33B | 15.34%989.81M | 858.14M |
Basic earnings per share | 34.69%0.66 | 13.95%0.49 | 0.43 |
Diluted earnings per share | |||
Currency Unit | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data